gvtcx

The Oncotype DX Breast Recurrence Score® test

The value below is a framework or dynamic market ceiling: the maximum that could be spent across all call-offs, not the value of a single contract. Aggregate figures on this site exclude these to avoid double counting.

key details

Value£77,760
Statuscomplete
Category (CPV) 38540000
Deadline1 Jun 2021
Contract start3 Jun 2021
Contract end4 Jun 2021
Procedureselective
SME suitableNo
OCIDocds-b5fd17-257d8604-cc19-4593-85ba-353d454debe3

Award

SupplierValueDateStatus
Exact Sciences UK Limited £77,760 1 Jun 2021 active

description

The Oncotype DX Breast Recurrence Score® test

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
9 Jun 2021 Award (award) · 187c593c-9cc2-4228-b340-f1dc70caea5a-442316

more from The Queen Elizabeth Hospital King's Lynn Nhs Foundation Trust

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.